The first head-to-head clinical trial (SURMOUNT-5, published in the New England Journal of Medicine in 2025) showed tirzepatide produced 20.2% average weight loss at 72 weeks compared to 13.7% for semaglutide approximately 47% greater relative weight loss
This minimizes enzymatic degradation and competition for absorption in the GI tract, ensuring a more consistent dose reaches circulation
STZ is a chemical used to induce diabetes, called streptozotocin
Always make decisions about your treatment in collaboration with your doctor.
Light, consistent activity is more beneficial than intense workouts when youre feeling tired
QiZ, LZ, YL, QH, TW, ZZ, LL, and YJ were in charge of daily animal feeding and environmental management